Link: 3M Health Care
Clinicians attending the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) learned today that there is a new weapon available in the fight against Methicillin-resistant Staphyloccocus aureus (commonly referred to as MRSA). Hospitals fighting the battle to stop the spread of the MRSA superbug will have access to a new five-hour culture-based test that detects the deadly bacteria direct from clinical specimens. The 3M™ BacLite™ Rapid MRSA Test launches today as the first rapid culture-based test that can effectively and reliably detect the presence or absence of MRSA in high risk patients within five hours.
